English

AstraZeneca PLC

ESEF

Report (type unavailable) · filed 2025-05-08

Annual consolidated revenue for 2024: about USD 54.07B, using the latest reported figures. The previous period, 2023, was about USD 45.81B.

Inspect reported changes Compare with another company Historical disclosures Segments

Watchlist

Latest fiscal year

Revenue

54.1 billion USD

2024 · USD

Exact inputs and evidence

Revenue: 54073000000 USD Source

Operating margin

18.5%

2024 · %

Exact inputs and evidence

Operating Income: 10003000000 USD Source
Revenue: 54073000000 USD Source

Operating cash flow

11.9 billion USD

2024 · USD

Exact inputs and evidence

Operating Cash Flow: 11861000000 USD Source

Free cash flow

9.94 billion USD

2024 · USD

Exact inputs and evidence

Operating Cash Flow: 11861000000 USD Source
Capital Expenditure: 1924000000 USD Source

Cash and cash equivalents: 5.49 billion USD 2024-12-31 Source
Exact value

5488000000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-05-08.

Financial data available through: 2024-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2024-12-31
Operating income: 6 of 11 periods available· newest 2024-12-31
Net income: 6 of 11 periods available· newest 2024-12-31
Operating cash flow: 6 of 11 periods available· newest 2024-12-31
Capital expenditure: 6 of 11 periods available· newest 2024-12-31
Total assets: 6 of 11 periods available· newest 2024-12-31
Total liabilities: 6 of 11 periods available· newest 2024-12-31
Current assets: 6 of 11 periods available· newest 2024-12-31
Current liabilities: 6 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2024-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+18%

Prior period

USD 45.81 billion

2023-01-01 – 2023-12-31
Current period

USD 54.07 billion

2024-01-01 – 2024-12-31

Exact inputs and evidence

54073000000 − 45811000000 = 8262000000 USD

45811000000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
54073000000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · AstraZeneca PLC · 2024-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Year-over-year change in Revenue: 8262000000 USD Concept: fundies:Revenue Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 54073000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#12893064 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 Input fundies:Revenue: 45811000000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#12893414 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0
The citation records this snapshot. The page link may show a newer release later.
Net income
+18.1%

Prior period

USD 5.96 billion

2023-01-01 – 2023-12-31
Current period

USD 7.04 billion

2024-01-01 – 2024-12-31

Exact inputs and evidence

7035000000 − 5955000000 = 1080000000 USD

5955000000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
7035000000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AstraZeneca PLC · 2024-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Year-over-year change in Net income: 1080000000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 7035000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#12933642 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 Input fundies:NetIncome: 5955000000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#12934018 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+14.7%

Prior period

USD 10.35 billion

2023-01-01 – 2023-12-31
Current period

USD 11.86 billion

2024-01-01 – 2024-12-31

Exact inputs and evidence

11861000000 − 10345000000 = 1516000000 USD

10345000000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
11861000000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AstraZeneca PLC · 2024-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Year-over-year change in Operating cash flow: 1516000000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 11861000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13181117 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 Input fundies:OperatingCashFlow: 10345000000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13181489 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+41.4%

Prior period

USD 1.36 billion

2023-01-01 – 2023-12-31
Current period

USD 1.92 billion

2024-01-01 – 2024-12-31

Exact inputs and evidence

1924000000 − 1361000000 = 563000000 USD

1361000000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
1924000000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · AstraZeneca PLC · 2024-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Year-over-year change in Capital expenditure: 563000000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1924000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13187142 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 Input fundies:CapitalExpenditure: 1361000000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13187545 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

Revenue USD 54.07 billion 100% of revenue
Operating costs Derived USD 44.07 billion 82% of revenue
Operating income USD 10 billion 18% of revenue
Tax, interest and other Derived USD 2.97 billion 5.5% of revenue
Net income USD 7.04 billion 13% of revenue

Cash

Operating cash flow USD 11.86 billion 22% of revenue
Capital expenditure USD 1.92 billion 3.6% of revenue
Free cash flow Derived USD 9.94 billion 18% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 88%
2020 12%81%
2021 97%
2022 92%
2023 13%82%
2024 13%82%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2019-01-01 – 2019-12-31	24384000000	21460000000 Derived	2924000000	1589000000 Derived	1335000000	1990000000 Derived	Source 2019-01-01 – 2019-12-31: 24384000000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 2924000000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: 1335000000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 2969000000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 979000000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	26617000000	21455000000 Derived	5162000000	1966000000 Derived	3196000000	3838000000 Derived	Source 2020-01-01 – 2020-12-31: 26617000000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 5162000000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 3196000000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 4799000000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 961000000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	37417000000	36361000000 Derived	1056000000	944000000 Derived	112000000	4872000000 Derived	Source 2021-01-01 – 2021-12-31: 37417000000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 1056000000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 112000000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 5963000000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 1091000000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	44351000000	40594000000 Derived	3757000000	469000000 Derived	3288000000	8717000000 Derived	Source 2022-01-01 – 2022-12-31: 44351000000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 3757000000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 3288000000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 9808000000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 1091000000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	45811000000	37618000000 Derived	8193000000	2238000000 Derived	5955000000	8984000000 Derived	Source 2023-01-01 – 2023-12-31: 45811000000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: 8193000000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: 5955000000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 10345000000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 1361000000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	54073000000	44070000000 Derived	10003000000	2968000000 Derived	7035000000	9937000000 Derived	Source 2024-01-01 – 2024-12-31: 54073000000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: 10003000000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 7035000000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 11861000000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 1924000000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 54.1B 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Revenue	24384000000	Revenue: 24384000000 Open source
20202020-12-31	Revenue	26617000000	Revenue: 26617000000 Open source
20212021-12-31	Revenue	37417000000	Revenue: 37417000000 Open source
20222022-12-31	Revenue	44351000000	Revenue: 44351000000 Open source
20232023-12-31	Revenue	45811000000	Revenue: 45811000000 Open source
20242024-12-31	Revenue	54073000000	Revenue: 54073000000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

18% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Year over year	No prior comparable period	Revenue: 24384000000 Open source
20202020-12-31	Year over year	9.2%	Revenue: 26617000000 Open source Revenue: 24384000000 Open source
20212021-12-31	Year over year	40.6%	Revenue: 37417000000 Open source Revenue: 26617000000 Open source
20222022-12-31	Year over year	18.5%	Revenue: 44351000000 Open source Revenue: 37417000000 Open source
20232023-12-31	Year over year	3.3%	Revenue: 45811000000 Open source Revenue: 44351000000 Open source
20242024-12-31	Year over year	18%	Revenue: 54073000000 Open source Revenue: 45811000000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 18.5% 2024

Net margin 13% 2024

Free cash flow margin 18.4% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Operating margin	12%	Operating Income: 2924000000 Open source Revenue: 24384000000 Open source
20202020-12-31	Operating margin	19.4%	Operating Income: 5162000000 Open source Revenue: 26617000000 Open source
20212021-12-31	Operating margin	2.8%	Operating Income: 1056000000 Open source Revenue: 37417000000 Open source
20222022-12-31	Operating margin	8.5%	Operating Income: 3757000000 Open source Revenue: 44351000000 Open source
20232023-12-31	Operating margin	17.9%	Operating Income: 8193000000 Open source Revenue: 45811000000 Open source
20242024-12-31	Operating margin	18.5%	Operating Income: 10003000000 Open source Revenue: 54073000000 Open source
20192019-12-31	Net margin	5.5%	Net Income: 1335000000 Open source Revenue: 24384000000 Open source
20202020-12-31	Net margin	12%	Net Income: 3196000000 Open source Revenue: 26617000000 Open source
20212021-12-31	Net margin	0.3%	Net Income: 112000000 Open source Revenue: 37417000000 Open source
20222022-12-31	Net margin	7.4%	Net Income: 3288000000 Open source Revenue: 44351000000 Open source
20232023-12-31	Net margin	13%	Net Income: 5955000000 Open source Revenue: 45811000000 Open source
20242024-12-31	Net margin	13%	Net Income: 7035000000 Open source Revenue: 54073000000 Open source
20192019-12-31	Free cash flow margin	8.2%	Revenue: 24384000000 Open source Operating Cash Flow: 2969000000 Open source Capital Expenditure: 979000000 Open source
20202020-12-31	Free cash flow margin	14.4%	Revenue: 26617000000 Open source Operating Cash Flow: 4799000000 Open source Capital Expenditure: 961000000 Open source
20212021-12-31	Free cash flow margin	13%	Revenue: 37417000000 Open source Operating Cash Flow: 5963000000 Open source Capital Expenditure: 1091000000 Open source
20222022-12-31	Free cash flow margin	19.7%	Revenue: 44351000000 Open source Operating Cash Flow: 9808000000 Open source Capital Expenditure: 1091000000 Open source
20232023-12-31	Free cash flow margin	19.6%	Revenue: 45811000000 Open source Operating Cash Flow: 10345000000 Open source Capital Expenditure: 1361000000 Open source
20242024-12-31	Free cash flow margin	18.4%	Revenue: 54073000000 Open source Operating Cash Flow: 11861000000 Open source Capital Expenditure: 1924000000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 11.9B 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Operating cash flow	2969000000	Operating Cash Flow: 2969000000 Open source
20202020-12-31	Operating cash flow	4799000000	Operating Cash Flow: 4799000000 Open source
20212021-12-31	Operating cash flow	5963000000	Operating Cash Flow: 5963000000 Open source
20222022-12-31	Operating cash flow	9808000000	Operating Cash Flow: 9808000000 Open source
20232023-12-31	Operating cash flow	10345000000	Operating Cash Flow: 10345000000 Open source
20242024-12-31	Operating cash flow	11861000000	Operating Cash Flow: 11861000000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 9.9B 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Free cash flow	1990000000	Operating Cash Flow: 2969000000 Open source Capital Expenditure: 979000000 Open source
20202020-12-31	Free cash flow	3838000000	Operating Cash Flow: 4799000000 Open source Capital Expenditure: 961000000 Open source
20212021-12-31	Free cash flow	4872000000	Operating Cash Flow: 5963000000 Open source Capital Expenditure: 1091000000 Open source
20222022-12-31	Free cash flow	8717000000	Operating Cash Flow: 9808000000 Open source Capital Expenditure: 1091000000 Open source
20232023-12-31	Free cash flow	8984000000	Operating Cash Flow: 10345000000 Open source Capital Expenditure: 1361000000 Open source
20242024-12-31	Free cash flow	9937000000	Operating Cash Flow: 11861000000 Open source Capital Expenditure: 1924000000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

60.7% 2024

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Liabilities / assets	76.2%	Total Liabilities: 46781000000 Open source Total Assets: 61377000000 Open source
20202020-12-31	Liabilities / assets	76.6%	Total Liabilities: 51091000000 Open source Total Assets: 66729000000 Open source
20212021-12-31	Liabilities / assets	62.7%	Total Liabilities: 66076000000 Open source Total Assets: 105363000000 Open source
20222022-12-31	Liabilities / assets	61.6%	Total Liabilities: 59425000000 Open source Total Assets: 96483000000 Open source
20232023-12-31	Liabilities / assets	61.3%	Total Liabilities: 61953000000 Open source Total Assets: 101119000000 Open source
20242024-12-31	Liabilities / assets	60.7%	Total Liabilities: 63164000000 Open source Total Assets: 104035000000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.93× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Current assets / current liabilities	0.86×	Current Assets: 15563000000 Open source Current Liabilities: 18117000000 Open source
20202020-12-31	Current assets / current liabilities	0.96×	Current Assets: 19544000000 Open source Current Liabilities: 20307000000 Open source
20212021-12-31	Current assets / current liabilities	1.16×	Current Assets: 26244000000 Open source Current Liabilities: 22594000000 Open source
20222022-12-31	Current assets / current liabilities	0.86×	Current Assets: 22593000000 Open source Current Liabilities: 26293000000 Open source
20232023-12-31	Current assets / current liabilities	0.82×	Current Assets: 25054000000 Open source Current Liabilities: 30542000000 Open source
20242024-12-31	Current assets / current liabilities	0.93×	Current Assets: 25827000000 Open source Current Liabilities: 27866000000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	USD 1.34 billion Exact value Exact value: 1335000000 USD 2019-01-01 – 2019-12-31: 1335000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AstraZeneca PLC · 2019-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Net Income: 1335000000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1335000000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2021-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2021-12-31.zip#31739478 Filing: PY6ZZQWO2IZFZC3IOL08-2021-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 2.97 billion Exact value Exact value: 2969000000 USD 2019-01-01 – 2019-12-31: 2969000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AstraZeneca PLC · 2019-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Operating Cash Flow: 2969000000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2969000000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2021-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2021-12-31.zip#31986012 Filing: PY6ZZQWO2IZFZC3IOL08-2021-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 979 million Exact value Exact value: 979000000 USD 2019-01-01 – 2019-12-31: 979000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AstraZeneca PLC · 2019-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Capital Expenditure: 979000000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 979000000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2021-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2021-12-31.zip#31993414 Filing: PY6ZZQWO2IZFZC3IOL08-2021-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 1.99 billion Calculation and evidence 2969000000 − 979000000 USD Exact free cash flow: 1990000000 USD 2019-01-01 – 2019-12-31: 2969000000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 979000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AstraZeneca PLC · 2019-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Free cash flow: 1990000000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2969000000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2021-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2021-12-31.zip#31986012 Filing: PY6ZZQWO2IZFZC3IOL08-2021-12-31-ESEF-SE-0 Input fundies:CapitalExpenditure: 979000000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2021-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2021-12-31.zip#31993414 Filing: PY6ZZQWO2IZFZC3IOL08-2021-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 3.2 billion Exact value Exact value: 3196000000 USD 2020-01-01 – 2020-12-31: 3196000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AstraZeneca PLC · 2020-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Net Income: 3196000000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3196000000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2021-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2021-12-31.zip#31739165 Filing: PY6ZZQWO2IZFZC3IOL08-2021-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 4.8 billion Exact value Exact value: 4799000000 USD 2020-01-01 – 2020-12-31: 4799000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AstraZeneca PLC · 2020-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Operating Cash Flow: 4799000000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4799000000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2021-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2021-12-31.zip#31985620 Filing: PY6ZZQWO2IZFZC3IOL08-2021-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 961 million Exact value Exact value: 961000000 USD 2020-01-01 – 2020-12-31: 961000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AstraZeneca PLC · 2020-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Capital Expenditure: 961000000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 961000000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2021-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2021-12-31.zip#31992993 Filing: PY6ZZQWO2IZFZC3IOL08-2021-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 3.84 billion Calculation and evidence 4799000000 − 961000000 USD Exact free cash flow: 3838000000 USD 2020-01-01 – 2020-12-31: 4799000000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 961000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AstraZeneca PLC · 2020-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Free cash flow: 3838000000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4799000000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2021-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2021-12-31.zip#31985620 Filing: PY6ZZQWO2IZFZC3IOL08-2021-12-31-ESEF-SE-0 Input fundies:CapitalExpenditure: 961000000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2021-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2021-12-31.zip#31992993 Filing: PY6ZZQWO2IZFZC3IOL08-2021-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 112 million Exact value Exact value: 112000000 USD 2021-01-01 – 2021-12-31: 112000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AstraZeneca PLC · 2021-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Net Income: 112000000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 112000000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2023-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2023-12-31.zip#21916259 Filing: PY6ZZQWO2IZFZC3IOL08-2023-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 5.96 billion Exact value Exact value: 5963000000 USD 2021-01-01 – 2021-12-31: 5963000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AstraZeneca PLC · 2021-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Operating Cash Flow: 5963000000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5963000000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2023-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2023-12-31.zip#22143637 Filing: PY6ZZQWO2IZFZC3IOL08-2023-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 1.09 billion Exact value Exact value: 1091000000 USD 2021-01-01 – 2021-12-31: 1091000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AstraZeneca PLC · 2021-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Capital Expenditure: 1091000000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1091000000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2023-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2023-12-31.zip#22150557 Filing: PY6ZZQWO2IZFZC3IOL08-2023-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 4.87 billion Calculation and evidence 5963000000 − 1091000000 USD Exact free cash flow: 4872000000 USD 2021-01-01 – 2021-12-31: 5963000000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 1091000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AstraZeneca PLC · 2021-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Free cash flow: 4872000000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5963000000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2023-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2023-12-31.zip#22143637 Filing: PY6ZZQWO2IZFZC3IOL08-2023-12-31-ESEF-SE-0 Input fundies:CapitalExpenditure: 1091000000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2023-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2023-12-31.zip#22150557 Filing: PY6ZZQWO2IZFZC3IOL08-2023-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 3.29 billion Exact value Exact value: 3288000000 USD 2022-01-01 – 2022-12-31: 3288000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AstraZeneca PLC · 2022-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Net Income: 3288000000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3288000000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#12934393 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 9.81 billion Exact value Exact value: 9808000000 USD 2022-01-01 – 2022-12-31: 9808000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AstraZeneca PLC · 2022-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Operating Cash Flow: 9808000000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 9808000000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13181861 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 1.09 billion Exact value Exact value: 1091000000 USD 2022-01-01 – 2022-12-31: 1091000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AstraZeneca PLC · 2022-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Capital Expenditure: 1091000000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1091000000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13187948 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 8.72 billion Calculation and evidence 9808000000 − 1091000000 USD Exact free cash flow: 8717000000 USD 2022-01-01 – 2022-12-31: 9808000000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 1091000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AstraZeneca PLC · 2022-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Free cash flow: 8717000000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 9808000000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13181861 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 Input fundies:CapitalExpenditure: 1091000000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13187948 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	USD 5.96 billion Exact value Exact value: 5955000000 USD 2023-01-01 – 2023-12-31: 5955000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AstraZeneca PLC · 2023-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Net Income: 5955000000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5955000000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#12934018 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 10.35 billion Exact value Exact value: 10345000000 USD 2023-01-01 – 2023-12-31: 10345000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AstraZeneca PLC · 2023-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Operating Cash Flow: 10345000000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 10345000000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13181489 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 1.36 billion Exact value Exact value: 1361000000 USD 2023-01-01 – 2023-12-31: 1361000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AstraZeneca PLC · 2023-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Capital Expenditure: 1361000000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1361000000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13187545 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 8.98 billion Calculation and evidence 10345000000 − 1361000000 USD Exact free cash flow: 8984000000 USD 2023-01-01 – 2023-12-31: 10345000000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 1361000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AstraZeneca PLC · 2023-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Free cash flow: 8984000000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 10345000000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13181489 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 Input fundies:CapitalExpenditure: 1361000000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13187545 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	USD 7.04 billion Exact value Exact value: 7035000000 USD 2024-01-01 – 2024-12-31: 7035000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AstraZeneca PLC · 2024-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Net Income: 7035000000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7035000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#12933642 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 11.86 billion Exact value Exact value: 11861000000 USD 2024-01-01 – 2024-12-31: 11861000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AstraZeneca PLC · 2024-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Operating Cash Flow: 11861000000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 11861000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13181117 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 1.92 billion Exact value Exact value: 1924000000 USD 2024-01-01 – 2024-12-31: 1924000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AstraZeneca PLC · 2024-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Capital Expenditure: 1924000000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1924000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13187142 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	USD 9.94 billion Calculation and evidence 11861000000 − 1924000000 USD Exact free cash flow: 9937000000 USD 2024-01-01 – 2024-12-31: 11861000000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 1924000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AstraZeneca PLC · 2024-12-31 AstraZeneca PLC (esef:PY6ZZQWO2IZFZC3IOL08) Free cash flow: 9937000000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/esef/PY6ZZQWO2IZFZC3IOL08?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 11861000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13181117 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 Input fundies:CapitalExpenditure: 1924000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/PY6ZZQWO2IZFZC3IOL08/2024-12-31/ESEF/SE/0/PY6ZZQWO2IZFZC3IOL08-2024-12-31.zip#13187142 Filing: PY6ZZQWO2IZFZC3IOL08-2024-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

3 filings · 489 latest values · 489 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: PY6ZZQWO2IZFZC3IOL08, esef:PY6ZZQWO2IZFZC3IOL08

AstraZeneca PLC

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2024 2024-01-01 – 2024-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation